Literature DB >> 8361769

Upregulation of mdm-2 expression in Meth A tumor cells tolerating wild-type p53.

A Otto1, W Deppert.   

Abstract

Overexpression of mouse wild-type p53 (wt p53) in mouse Meth A tumor cells after transfection of wt p53 encoding vectors induced a strong growth-inhibitory response. Cells of only few of randomly selected surviving colonies contained and expressed the transfected wt p53 specific DNA. Despite expressing authentic wt p53, such cells (MethAp53wt) exhibited a similar phenotype as the parental Meth A cells. These cells overexpressed the mdm-2 (mouse double minute-2) gene, both at the RNA and at the protein level. Recently, the MDM-2 protein has been identified as a cellular target of p53, which can abolish its tumor suppressor activity. We, therefore, suggest that MDM-2 has mitigated the growth-inhibitory effect of wt p53 in MethAp53wt cells. Upregulation of mdm-2 expression in MethAp53wt cells was mediated by wt p53, as analysis of Meth A cells carrying a tsp53 (p53Val135) revealed a strict dependence of mdm-2 upregulation upon wt p53 expression. Our results propose that a balanced ratio of MDM-2 and p53 will allow cells to tolerate a limited expression of wt p53. This tolerance is not mediated by a direct inactivation of wt p53 via complex formation with MDM-2, as the majority of both MDM-2 and wt p53 in MethAp53wt cells was not complexed to each other.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8361769

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection.

Authors:  W Henning; G Rohaly; T Kolzau; U Knippschild; H Maacke; W Deppert
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  The Mdm2 oncoprotein interacts with the cell fate regulator Numb.

Authors:  T Juven-Gershon; O Shifman; T Unger; A Elkeles; Y Haupt; M Oren
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

3.  The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis.

Authors:  D R Brown; C A Thomas; S P Deb
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

4.  p53 binds to and is required for the repression of Arf tumor suppressor by HDAC and polycomb.

Authors:  Yaxue Zeng; Yojiro Kotake; Xin-Hai Pei; Matthew D Smith; Yue Xiong
Journal:  Cancer Res       Date:  2011-03-29       Impact factor: 12.701

5.  Physical and functional interaction between wild-type p53 and mdm2 proteins.

Authors:  D S Haines; J E Landers; L J Engle; D L George
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

6.  Abnormal expression of MDM-2 in breast carcinomas.

Authors:  C E Bueso-Ramos; T Manshouri; M A Haidar; Y Yang; P McCown; N Ordonez; A Glassman; N Sneige; M Albitar
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.

Authors:  J Chen; J Lin; A J Levine
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

Review 8.  P53, cell cycle control and apoptosis: implications for cancer.

Authors:  M B Kastan; C E Canman; C J Leonard
Journal:  Cancer Metastasis Rev       Date:  1995-03       Impact factor: 9.264

9.  A functional p53-responsive intronic promoter is contained within the human mdm2 gene.

Authors:  A Zauberman; D Flusberg; Y Haupt; Y Barak; M Oren
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

10.  Cell type-specific inhibition of p53-mediated apoptosis by mdm2.

Authors:  Y Haupt; Y Barak; M Oren
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.